Metfendrazine

From WikiMD's Wellnesspedia

Metfendrazine is a stimulant drug which was developed in the 1960s. It is related to phenmetrazine, a once-popular stimulant that was later banned due to abuse potential. Metfendrazine is less well-known and is not currently in widespread use.

History[edit | edit source]

Metfendrazine was first synthesized in the 1960s, around the same time as its better-known relative, phenmetrazine. Both drugs were developed as potential treatments for conditions such as obesity, narcolepsy, and ADHD. However, phenmetrazine was found to have a high potential for abuse and was eventually banned in many countries. Metfendrazine, on the other hand, has not been as widely studied or used.

Pharmacology[edit | edit source]

Like other stimulant drugs, metfendrazine works by increasing the levels of certain neurotransmitters in the brain. These include dopamine, norepinephrine, and serotonin, which are involved in regulating mood, energy levels, and attention. However, the exact mechanism of action of metfendrazine is not fully understood.

Potential Uses[edit | edit source]

While metfendrazine is not currently approved for any medical uses, it has been studied as a potential treatment for conditions such as obesity and ADHD. However, more research is needed to determine its efficacy and safety for these uses.

Side Effects and Risks[edit | edit source]

As a stimulant, metfendrazine can have a number of side effects. These may include insomnia, increased heart rate, elevated blood pressure, and anxiety. There is also a risk of dependence and abuse, similar to other stimulant drugs.

Legal Status[edit | edit source]

The legal status of metfendrazine varies by country. In some places, it is classified as a controlled substance, while in others it is not regulated.

See Also[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD